DOCSLIB.ORG

BIS's Capital Investment in Science Projects

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
BIS's Capital Investment in Science Projects Report by the Comptroller and Auditor General Department for Business, Innovation & Skills BIS’s capital investment in science projects HC 885 SESSION 2015-16 10 MARCH 2016 Our vision is to help the nation spend wisely. Our public audit perspective helps Parliament hold government to account and improve public services. The National Audit Office scrutinises public spending for Parliament and is independent of government. The Comptroller and Auditor General (C&AG), Sir Amyas Morse KCB, is an Officer of the House of Commons and leads the NAO, which employs some 810 people. The C&AG certifies the accounts of all government departments and many other public sector bodies. He has statutory authority to examine and report to Parliament on whether departments and the bodies they fund have used their resources efficiently, effectively, and with economy. Our studies evaluate the value for money of public spending, nationally and locally. Our recommendations and reports on good practice help government improve public services, and our work led to audited savings of £1.15 billion in 2014. Department for Business, Innovation & Skills BIS’s capital investment in science projects Report by the Comptroller and Auditor General Ordered by the House of Commons to be printed on 8 March 2016 This report has been prepared under Section 6 of the National Audit Act 1983 for presentation to the House of Commons in accordance with Section 9 of the Act Sir Amyas Morse KCB Comptroller and Auditor General National Audit Office 4 March 2016 HC 885 | £10.00 This report examines whether the Department for Business, Innovation & Skills (BIS) can demonstrate it is achieving value for money from its investment in science projects. © National Audit Office 2016 The material featured in this document is subject to National Audit Office (NAO) copyright. The material may be copied or reproduced for non-commercial purposes only, namely reproduction for research, private study or for limited internal circulation within an organisation for the purpose of review. Copying for non-commercial purposes is subject to the material being accompanied by a sufficient acknowledgement, reproduced accurately, and not being used in a misleading context. To reproduce NAO copyright material for any other use, you must contact [email protected]. Please tell us who you are, the organisation you represent (if any) and how and why you wish to use our material. Please include your full contact details: name, address, telephone number and email. Please note that the material featured in this document may not be reproduced for commercial gain without the NAO’s express and direct permission and that the NAO reserves its right to pursue copyright infringement proceedings against individuals or companies who reproduce material for commercial gain without our permission. Links to external websites were valid at the time of publication of this report. The National Audit Office is not responsible for the future validity of the links. 10905 03/16 NAO Contents Key facts 4 Summary 5 Part One Background 12 Part Two Deciding capital priorities 18 Part Three Performance and impact 31 Appendix One Our audit approach 41 Appendix Two Our evidence base 44 Appendix Three Scope of the review 50 The National Audit Office study team consisted of: Kevin Coughlan, Cornelius Halladay-Garrett, Rachel Kift, Sonia Sousa and Heather Thompson, under the direction of Peter Gray. This report can be found on the National Audit Office website at www.nao.org.uk For further information about the National Audit Office please contact: National Audit Office Press Office 157–197 Buckingham Palace Road Victoria London SW1W 9SP Tel: 020 7798 7400 Enquiries: www.nao.org.uk/contact-us Website: www.nao.org.uk Twitter: @NAOorguk 4 Key facts BIS’s capital investment in science projects Key facts £1.1bn £5.9bn 56 total capital expenditure on the total amount BIS National Audit Offi ce estimate science by the Department for announced it plans to spend of the number of major Business, Innovation & Skills on major science projects science projects that BIS has (BIS) in 2014-15 between 2016 and 2021 committed to fund since 2007 £3.2 billion National Audit Offi ce estimate of the amount BIS has spent or has committed to spend on 56 major science projects since 2007. This does not include capital funding allocated by higher education funding bodies to universities. For the purposes of our report, we defi ned major projects as those with a capital cost greater than £2 million. £500 million allocated by Higher Education Funding Council for England (HEFCE) to universities through its UK Research Partnership Investment Fund since 2012. This fund is designed to support investment in higher education research facilities. 15 number of new projects that BIS selected following its capital consultation in 2014 (subject to business case approval). BIS’s capital investment in science projects Summary 5 Summary 1 The government invests in science to support economic growth, improve national productivity and help the UK take the lead in new markets. The Department for Business, Innovation & Skills (BIS) has overall responsibility for the government’s spending on science, technology and engineering. It also provides funding for a wide range of scientific disciplines and industry sectors with the aim of developing and maintaining the UK’s science and research capability. 2 In 2014-15, BIS allocated £1.1 billion of capital funding to science (Figure 1). This covered its expenditure on major national projects such as oceanographic research ships, supercomputers and research institutes, capital funding for large national research facilities such as particle accelerators, and the UK’s participation in international programmes such as the European Space Agency. It also covered capital funding allocated by the Higher Education Funding Council for England (HEFCE) for laboratories and research facilities in universities. Figure 1 BIS’s capital funding of science (2014-15) BIS’s capital funding of science (2014-15) £1.1 billion1 Science capital funding for 7 research councils and the Science capital funding for the Higher Education Funding UK Space Agency (£756m) Council for England (£287m) Projects Research International Large UK Research Partnership Other capital grants for (£427m) councils and subscriptions national Investment Fund (£160m) universities (£127m) UK Space (£28m) facilities Agency core (£23m) capital budget2 (£278m) Notes 1 Department for Business, Innovation & Skills’s capital funding of science also includes £15 million funding allocated to higher education funding bodies in Scotland, Wales and Northern Ireland, totalling £1.058 billion (rounds to £1.1 billion). 2 The research councils’ core budget covers expenditure on minor projects or upgrades, capital grants and the research councils’ estates expenditure. Source: National Audit Offi ce 6 Summary BIS’s capital investment in science projects 3 In December 2014 BIS announced plans for a further £5.9 billion of capital expenditure on science between 2016 and 2021. This included £800 million for new projects, more than £1.2 billion for ongoing national and international projects and a £900 million fund to respond to new challenges as they emerge. It also included plans to spend around £3 billion on the underlying laboratory infrastructure in universities or research institutes. The 2015 Spending Review confirmed this level of future funding. Under the Haldane principle, the government does not take decisions on whether to fund specific projects or individual research proposals. However, ministers have the final say in decisions that involve large-scale, long-term commitments such as the construction of large research facilities. 4 We last reported on the government’s spending on large science facilities in 2007.1 The report was generally positive about BIS’s delivery of a significant capital programme and how it and the research councils had set about prioritising project proposals. Our report did, however, raise concerns about how BIS assessed the ongoing costs of projects and the impact of meeting those costs on the balance of activities funded by the research councils. We also concluded that BIS needed to give more attention to specifying from the start how to assess and measure the success of individual projects. 5 A report published in 2013 by the House of Lords Science and Technology Committee2 raised concerns that the cost of running large-scale infrastructure had not been budgeted for. It also concluded that the potential of the UK’s large-scale scientific resources is being compromised by the lack of a long-term strategic investment plan. In response, BIS launched a public consultation in 2014 to identify strategic priorities for science investment. 6 Reports published in 2015 by the House of Commons Science and Technology Committee and by Sir Paul Nurse acknowledged that the UK research base is world-leading, producing excellent research in a competitive system.3,4 However, they also emphasised the importance of ensuring capital investments are accompanied by sufficient resource funding. Between 2010 and 2014, science resource funding fell in real terms. The 2015 Spending Review committed to maintain science resource at £4.7 billion in real terms up to 2021. 1 Comptroller and Auditor General, Big Science: Public investment in large scientific facilities, Session 2006-07, HC 153, National Audit Office, January 2007. 2 House of Lords Select Committee on Science & Technology, Scientific Infrastructure, 2013. 3 House of Commons Select Committee on Science & Technology, The science budget, 2015. 4 Sir Paul Nurse, A review of the UK research councils, Ensuring a successful UK science endeavour, November 2015. BIS’s capital investment in science projects Summary 7 Scope and approach 7 This report covers BIS’s investment in large facilities and other national and international capital projects managed by the research councils, and capital projects managed by HEFCE through its UK Research Partnership Investment Fund (UKRPIF).
Load more

Recommended publications
  • Wellcome Trust Annual Report and Financial Statements 2017 Contents
    Annual Report and Financial Statements 2017 2 Wellcome Trust Annual Report and Financial Statements 2017 Contents Report from the Chair and the Director 5 Trustee’s Report 8 What we do 8 Review of Charitable Activities 9 Review of Investment Activities 18 Financial Review 29 Structure and Governance 34 Risk Management 37 Remuneration Report 40 Audit Committee Report 43 Independent Auditor’s Report 45 Financial Statements 58 Consolidated Statement of Financial Activities 58 Consolidated Balance Sheet 59 Statement of Financial Activities of the Trust 60 Balance Sheet of the Trust 61 Consolidated Cash Flow Statement 62 Notes to the Financial Statements 63 Reference and Administrative Details 117 3 Wellcome Trust Annual Report and Financial Statements 2017 “ At Wellcome, we believe in the power of ideas to improve health” Jeremy Farrar Director 4 Wellcome Trust Annual Report and Financial Statements 2017 Report from the Chair and the Director “Our core approach is funding people to explore great ideas, at every step of the way from discovery to impact” At Wellcome, we believe in the power of ideas to improve cause of maternal mortality in the world. It also includes health. Funded from our independent investment portfolio, supporting research in the humanities and social sciences, we support thousands of scientists and researchers in more such as a project which this year published ethical guidelines than 70 countries, as well as innovators, educators and artists. for involving pregnant women in Zika vaccine research. Together, we take on big problems, fuel imaginations and spark And resources like the Human Induced Pluripotent Stem Cell debate, working always to achieve better health for everyone.
    [Show full text]
  • The Electron Microscopy Science Technology Platform at the Francis
    The Francis Crick Institute is a The Electron biomedical discovery institute Microscopy dedicated to understanding the fundamental biology underlying Science health and disease. Its work Technology is helping to understand why disease develops and to translate Platform at discoveries into new ways to the Francis prevent, diagnose and treat illnesses such as cancer, heart Crick Institute disease, stroke, infections, and Lucy Collinson neurodegenerative diseases. An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, University College London, Imperial College London and King’s College London. The Crick was formed in 2015, with many of the Crick’s scientists joining from two ‘parent’ institutes, the MRC’s National Institute for Medical Research and Cancer Research UK’s London Research Institute, and in 2016 it moved into a brand new state-of- the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under a single roof in Europe. © Nick Guttridge 4 ISSUE 46 JUNE 2017 5 Each microscope room is a six-sided shielded box, • The Phenom-World DelPhi benchtop SEM with walls that contain complex metallic layers has an integrated fluorescence microscope to attenuate DC fields, and an active cancellation for correlative imaging system to attenuate AC fields. Under each • The FEI Twin 120 kV TEM has a cryo stage for microscope is a concrete platform, cast in place, and screening vitrified macromolecular samples supported by air springs that remove environmental prior to imaging on 200 kV and 300 kV TEMs vibration to <1 Hz.
    [Show full text]
  • Structure of Human Aspartyl Aminopeptidase Complexed With
    Chaikuad et al. BMC Structural Biology 2012, 12:14 http://www.biomedcentral.com/1472-6807/12/14 RESEARCH ARTICLE Open Access Structure of human aspartyl aminopeptidase complexed with substrate analogue: insight into catalytic mechanism, substrate specificity and M18 peptidase family Apirat Chaikuad1, Ewa S Pilka1, Antonio De Riso2, Frank von Delft1, Kathryn L Kavanagh1, Catherine Vénien-Bryan2, Udo Oppermann1,3 and Wyatt W Yue1* Abstract Backround: Aspartyl aminopeptidase (DNPEP), with specificity towards an acidic amino acid at the N-terminus, is the only mammalian member among the poorly understood M18 peptidases. DNPEP has implicated roles in protein and peptide metabolism, as well as the renin-angiotensin system in blood pressure regulation. Despite previous enzyme and substrate characterization, structural details of DNPEP regarding ligand recognition and catalytic mechanism remain to be delineated. Results: The crystal structure of human DNPEP complexed with zinc and a substrate analogue aspartate-β- hydroxamate reveals a dodecameric machinery built by domain-swapped dimers, in agreement with electron microscopy data. A structural comparison with bacterial homologues identifies unifying catalytic features among the poorly understood M18 enzymes. The bound ligands in the active site also reveal the coordination mode of the binuclear zinc centre and a substrate specificity pocket for acidic amino acids. Conclusions: The DNPEP structure provides a molecular framework to understand its catalysis that is mediated by active site loop swapping, a mechanism likely adopted in other M18 and M42 metallopeptidases that form dodecameric complexes as a self-compartmentalization strategy. Small differences in the substrate binding pocket such as shape and positive charges, the latter conferred by a basic lysine residue, further provide the key to distinguishing substrate preference.
    [Show full text]
  • A Critical Base Pair in K-Turns That Confers Folding Characteristics and Correlates with Biological Function
    ARTICLE Received 16 Apr 2014 | Accepted 2 Sep 2014 | Published 29 Oct 2014 DOI: 10.1038/ncomms6127 OPEN A critical base pair in k-turns that confers folding characteristics and correlates with biological function Scott A. McPhee1, Lin Huang1 & David M.J. Lilley1 Kink turns (k-turns) are widespread elements in RNA that mediate tertiary contacts by kinking the helical axis. We have found that the ability of k-turns to undergo ion-induced folding is conferred by a single base pair that follows the conserved AG pairs, that is, the 3b3n position. A Watson–Crick pair leads to an inability to fold in metal ions alone, while 3n ¼ Gor3b¼ C (but not both) permits folding. Crystallographic study reveals two hydrated metal ions coordinated to O6 of G3n and G2n of Kt-7. Removal of either atom impairs Mg2 þ - induced folding in solution. While SAM-I riboswitches have 3b3n sequences that would predispose them to ion-induced folding, U4 snRNA are strongly biased to an inability to such folding. Thus riboswitch sequences allow folding to occur independently of protein binding, while U4 should remain unfolded until bound by protein. The empirical rules deduced for k-turn folding have strong predictive value. 1 Cancer Research UK Nucleic Acid Structure Research Group, MSI/WTB Complex, The University of Dundee, Dow Street, Dundee DD1 5EH, UK. Correspondence and requests for materials should be addressed to D.M.J.L. (email: [email protected]). NATURE COMMUNICATIONS | 5:5127 | DOI: 10.1038/ncomms6127 | www.nature.com/naturecommunications 1 & 2014 Macmillan Publishers Limited.
    [Show full text]
  • Living Healthier for Longer Sharing Data Saves Lives
    News from the Medical Research Council network Spring 2014 Leading science for better health MEASUREto How some MRC scientific workshops are making custom-made kit to enable pioneering research Living healthier for longer Supporting innovative ageing research through the Lifelong Health and Wellbeing initiative Sharing data saves lives Opinions from two MRC researchers Network can also be downloaded as a PDF at: www.mrc.ac.uk/network CONTENTS NEWS News COMMENT FROM £39.1m for improving data research 3 £39.1m for improving Science festival fun 4 John Let’s talk about dementia 7 data research Savill A £32m MRC investment, announced by Universities and Science the MRC Consortium for Medical Microbial Bioinformatics led by Minister David Willetts at the High Performance Computing and Warwick University, the Medical Bioinformatics partnership led People CHIEF EXECUTIVE Big Data Conference in London on 6 February, plus an additional by Imperial College London and University College London £7.1m, is the latest instalment of a £90m funding initiative to Partners which includes the Francis Crick Institute, will also Dr Jane Cope on the power of persuasion 9 In February, the Minister for tackle health and bioinformatics challenges for the advancement support career opportunities for computational scientists, Universities and Science David of medical research. technologists and programme leaders, enhancing the UK’s skills Willetts announced a £32m MRC in this area. investment into improving the UK’s Six major strategic awards will strengthen collaborative links, capability in, and capacity for, improve tools and infrastructure for researchers and support the Mr Willets said: “Making the most of large and complex data is a Latest discoveries medical bioinformatics.
    [Show full text]
  • The Diamond Light Source
    The Diamond Light Source ... a bright future for UK and World science Richard P. Walker, Technical Director What is Diamond ? • The largest scientific investment in the UK for 30 years • A synchrotron light source producing pinpoint UV and X-ray light beams of exceptional brightness • A ‘super microscope’ for new research opportunities into the structure and properties of matter What is Diamond ? • A Power Converter ! 15 MW of electrical power from the grid … 300-500 kW of X-rays … … but most of which only produces unwanted heat; only a fraction is selected for use in experiments. What is Synchrotron Radiation ? SR is electromagnetic radiation emitted when a high energy beam of charged particles (electrons) is deflected by a magnetic field. What’s so special about Synchrotron Radiation ? SR SR is emitted over a wide range of the electromagnetic spectrum, from Infra-red to hard X-rays Any desired radiation wavelength can be produced - enabling a very wide range of scientific and technological applications What’s so special about Synchrotron Radiation ? SR is very intense, and has extremely high brightness (emitted from a small area, with small angular divergence, determined by the properties of the electron beam) High brightness means: - it can be focused to sub-micron spot sizes: possibility of examining extremely small samples or investigating the structure and properties of objects with very fine spatial resolution - experiments can be carried out much more quickly: high through-put of samples or ability to follow chemical and biological reactions in real-time Diamond is a “third-generation” synchrotron radiation source • 1st generation: machines originally built for other purposes e.g.
    [Show full text]
  • Structural Basis of Mammalian Mucin Processing by the Human Gut O
    ARTICLE https://doi.org/10.1038/s41467-020-18696-y OPEN Structural basis of mammalian mucin processing by the human gut O-glycopeptidase OgpA from Akkermansia muciniphila ✉ ✉ Beatriz Trastoy 1,4, Andreas Naegeli2,4, Itxaso Anso 1,4, Jonathan Sjögren 2 & Marcelo E. Guerin 1,3 Akkermansia muciniphila is a mucin-degrading bacterium commonly found in the human gut that promotes a beneficial effect on health, likely based on the regulation of mucus thickness 1234567890():,; and gut barrier integrity, but also on the modulation of the immune system. In this work, we focus in OgpA from A. muciniphila,anO-glycopeptidase that exclusively hydrolyzes the peptide bond N-terminal to serine or threonine residues substituted with an O-glycan. We determine the high-resolution X-ray crystal structures of the unliganded form of OgpA, the complex with the glycodrosocin O-glycopeptide substrate and its product, providing a comprehensive set of snapshots of the enzyme along the catalytic cycle. In combination with O-glycopeptide chemistry, enzyme kinetics, and computational methods we unveil the molecular mechanism of O-glycan recognition and specificity for OgpA. The data also con- tribute to understanding how A. muciniphila processes mucins in the gut, as well as analysis of post-translational O-glycosylation events in proteins. 1 Structural Biology Unit, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain. 2 Genovis AB, Box 790, 22007 Lund, Sweden. 3 IKERBASQUE, Basque Foundation for Science, 48013 ✉ Bilbao, Spain. 4These authors contributed equally: Beatriz Trastoy, Andreas Naegeli, Itxaso Anso.
    [Show full text]
  • Structure and Ligand Binding of the ADP-Binding Domain of the NAD+ Riboswitch
    Downloaded from rnajournal.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press Structure and ligand binding of the ADP-binding domain of the NAD+ riboswitch Lin Huang1, Jia Wang and David M. J. Lilley* Cancer Research UK Nucleic Acid Structure Research Group, MSI/WTB Complex, The University of Dundee, Dow Street, Dundee DD1 5EH, U.K. * To whom correspondence should be addressed 1. Current address : Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120 , P. R. China and RNA Biomedical Institute, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, P. R. China Keywords : Riboregulation; RNA structure; X-ray crystallography; metal ions; nucleotide binding Running title: The structure of the NAD+ riboswitch Submitted to the RNA journal 20 January 2020 Editorial enquiries to Professor Lilley: Tel: (+44)-1382-384243 Email: [email protected] Downloaded from rnajournal.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press ABSTRACT The nadA motif is the first known NAD+-dependent riboswitch, comprising two similar tandem bulged stem-loop structures. We have determined the structure of the 5’ domain 1 of the riboswitch. It has three coaxial helical segments, separated by an ACANCCCC bulge and by an internal loop, with a tertiary contact between them that includes two C:G base pairs. We have determined the structure with a number of ligands related to NADH, but in each case only the ADP moiety is observed. The adenosine adopts an anti conformation, and forms multiple hydrogen bonds across the width of the sugar edge of the penultimate C:G base pair of the helix preceding the bulge, and the observed contacts have been confirmed by mutagenesis and calorimetry.
    [Show full text]
  • Wellcome Trust Annual Report and Financial Statements 2019 Is © the Wellcome Trust and Is Licensed Under Creative Commons Attribution 2.0 UK
    Annual Report and Financial Statements 2019 Table of contents Report from Chair 3 Report from Director 5 Trustee’s Report 7 What we do 8 Review of Charitable Activities 9 Review of Investment Activities 21 Financial Review 31 Structure and Governance 36 Social Responsibility 40 Risk Management 42 Remuneration Report 44 Remuneration Committee Report 46 Nomination Committee Report 47 Investment Committee Report 48 Audit and Risk Committee Report 49 Independent Auditor’s Report 52 Financial Statements 61 Consolidated Statement of Financial Activities 62 Consolidated Balance Sheet 63 Statement of Financial Activities of the Trust 64 Balance Sheet of the Trust 65 Consolidated Cash Flow Statement 66 Notes to the Financial Statements 67 Alternative Performance Measures and Key Performance Indicators 114 Glossary of Terms 115 Reference and Administrative Details 116 Table of Contents Wellcome Trust Annual Report 2019 | 2 Report from Chair During my tenure at Wellcome, which ends in The macro environment is increasingly challenging, 2020, I count myself lucky to have had the which has created volatility in financial markets. opportunity to meet inspiring people from a rich Q4 2018 was a very difficult quarter, but the diversity of sectors, backgrounds, specialisms resumption of interest rate cuts by the US Federal and scientific fields. Reserve underpinned another year of gains for our portfolio. We recognise that the cycle is extended, Wellcome’s achievements belong to the people and that the portfolio is likely to face more who work here and to the people we fund – it is challenging times ahead. a partnership that continues to grow stronger, more influential and more ambitious, spurred by The team is working hard to ensure that our independence.
    [Show full text]
  • Guidance for Applicants
    Guidance for applicants The British Academy, Royal Academy of Engineering and A full list of the disciplines covered by the Academies can the Royal Society are three of five Designated Competent be found in the ‘Guidance on Policy for UK visas under Tier Bodies (DCBs) appointed by the Home Office to assess 1 (Exceptional Talent)’ document available on the Home applications for the Research and Innovation Talent Visa Office website. under the Home Office Tier 1 (Exceptional Talent) Visa route. Holders of a Research and Innovation Talent Visa that were As DCBs, the Academies are responsible for considering endorsed through Exceptional Talent are eligible to apply whether an individual who makes an application for settlement (Indefinite Leave to Remain) after three years. is demonstrably ‘exceptionally talented’ or has Holders endorsed through Exceptional Promise are eligible ‘exceptional promise’. after five years. Tier 1 (Exceptional Talent) is subject to a limit of 2,000 visas per year (beginning on 6 April one year and ending on 5 April the following year). The Academies assess applications in the following areas and are allocated a minumum number of endorsements by the Home Office from the total annual pool. • The British Academy – for humanities and social sciences (150 endorsements); • The Royal Society – for natural sciences and medical science research (250 endorsements); • The Royal Academy of Engineering – for engineering (150 endorsements). TIER 1 APPLICATION GUIDANCE 1 Overview of the application process The application for a Research & Innovation Talent visa Should the decision be upheld then the process ends here. (Tier 1 Exceptional Talent) is in two stages: You can still apply via another visa route or re-apply to this route with revised supporting evidence.
    [Show full text]
  • Quadram Institute Newsletter
    Autumn 2019 Welcome to the newsle�er of the Quadram Ins�tute. This issue highlights recent research breakthroughs at the We con�nue to build our team and are pleased to welcome Quadram Ins�tute (QI) that could have posi�ve impacts on Professor Cynthia Whitchurch to the QI. Cynthia is se�ng public health. Working with clinicians our researchers have up a research group inves�ga�ng bacterial lifestyles, and shown how the latest sequencing technologies can aid in how these make them more infec�ous or resistant to diagnos�cs and surveillance. Coupling these techniques an�microbials. Cynthia joins us from the ithree ins�tute at with ‘Big Data’ analy�cal approaches will be vital to the University of Technology Sydney. Her research led to addressing 21st century popula�on health challenges, and the discovery that extracellular DNA is required for biofilm the QI aims to be a leader in this area. development. Big Data in the NHS was the topic of a roundtable We con�nue to welcome visitors to our new building to discussion I a�ended with Patricia Hart at the policy share our vision to understand how food and microbes development think tank Reform. This roundtable was interact to promote health and prevent disease. In June, we sponsored by QI and explored how universi�es and industry had the honour of hos�ng His Excellency Simon Smits, can work with government to realise poten�al applica�ons Ambassador of the Netherlands to the UK. The Ambassador of Big Data. The event was chaired by Baroness Blackwood, visited the Norwich Research Park as part of an Parliamentary Under-Secretary of State, Department of interna�onal trade delega�on to East Anglia to learn about Health and Social Care (DHSC) and included senior the region’s world-leading life sciences research and trade policy-makers, public service prac��oners, academics and opportuni�es.
    [Show full text]
  • Economic Evaluation Report the Economic Impact of Creating A
    Economic Evaluation Report The economic impact of creating a congestion free, energy independent city Prepared for Exeter City Futures by Vivid Economics 1 Contents Executive Summary ........................................................................................ 5 1 Urban Development Framework ........................................................... 7 2 Exeter Area Baseline ............................................................................ 12 3 Potential Impact of Energy Independence .......................................... 27 4 Potential Impact of Transport Innovation ........................................... 44 5 Opportunities for export-oriented businesses .................................... 58 6 Conclusion............................................................................................. 62 Bibliography .......................................................................................................... 64 Appendix 1 – Assumptions and Sources in the Energy Efficiency Analysis .......... 66 Appendix 2 – Defining Congestion ....................................................................... 71 Appendix 3 – Transportation Case Studies .......................................................... 73 Appendix 4 – Sensitivity Analysis ......................................................................... 77 Appendix 5 - Innovation Initiatives and Programmes .......................................... 78 Appendix 6 – Complexity Analysis .......................................................................
    [Show full text]